Aemetis Inc. (NASDAQ:AMTX) had its target price increased by FBR & Co to $2.00 in a report released on Monday morning. FBR & Co currently has a hold rating on the stock.

Separately, Zacks Investment Research upgraded Aemetis from a sell rating to a hold rating in a report on Tuesday, November 8th.

Shares of Aemetis (NASDAQ:AMTX) traded up 3.39% on Monday, hitting $1.83. The stock had a trading volume of 12,372 shares. Aemetis has a 52-week low of $1.01 and a 52-week high of $3.05. The firm’s market cap is $36.34 million. The firm’s 50-day moving average price is $1.60 and its 200 day moving average price is $1.89.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Monday, November 14th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.27) by $0.06. On average, equities research analysts predict that Aemetis will post ($1.04) EPS for the current year.

A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC increased its stake in Aemetis Inc. (NASDAQ:AMTX) by 4.9% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,453,131 shares of the company’s stock after buying an additional 68,460 shares during the period. Geneva Advisors LLC owned about 7.32% of Aemetis worth $1,569,000 as of its most recent filing with the SEC. 18.57% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

5 Day Chart for NASDAQ:AMTX

Receive News & Stock Ratings for Aemetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc. and related stocks with our FREE daily email newsletter.